Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Scharf

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Journal of Organic Chemistry|June 4, 2013
Highly stereocontrolled total synthesis of β-D-mannosyl phosphomycoketide: a natural product from Mycobacterium tuberculosisNan-Sheng Li, Louise Scharf, Erin J Adams, et al.
Current Opinion in HIV and AIDS|March 12, 2015
Antibody engineering for increased potency, breadth and half-lifeStuart A Sievers, Louise Scharf, Anthony P West, et al.
Science (New York, N.Y.)|September 14, 2013
Antibodies in HIV-1 vaccine development and therapyFlorian Klein, Hugo Mouquet, Pia Dosenovic, et al.
Cell|September 12, 2015
Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 EnvLouise Scharf, Haoqing Wang, Han Gao, et al.
The Journal of Biological Chemistry|January 5, 2012
γδ T cell receptors recognize the non-classical major histocompatibility complex (MHC) molecule T22 via conserved anchor residues in a MHC peptide-like fashionAndrew Sandstrom, Louise Scharf, Gabrielle McRae, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2013
Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residuesAnthony P West, Louise Scharf, Joshua Horwitz, et al.
Cell|February 18, 2014
Structural insights on the role of antibodies in HIV-1 vaccine and therapyAnthony P West, Louise Scharf, Johannes F Scheid, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2013
Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibodyLouise Scharf, Anthony P West, Han Gao, et al.
Plos One|August 17, 2017
Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in miceFlavia Chiuppesi, Felix Wussow, Louise Scharf, et al.
Elife|May 27, 2017
Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodiesHaoqing Wang, Harry B Gristick, Louise Scharf, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Organic Chemistry|June 4, 2013
Highly stereocontrolled total synthesis of β-D-mannosyl phosphomycoketide: a natural product from Mycobacterium tuberculosisNan-Sheng Li, Louise Scharf, Erin J Adams, et al.
Current Opinion in HIV and AIDS|March 12, 2015
Antibody engineering for increased potency, breadth and half-lifeStuart A Sievers, Louise Scharf, Anthony P West, et al.
Science (New York, N.Y.)|September 14, 2013
Antibodies in HIV-1 vaccine development and therapyFlorian Klein, Hugo Mouquet, Pia Dosenovic, et al.
Cell|September 12, 2015
Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 EnvLouise Scharf, Haoqing Wang, Han Gao, et al.
The Journal of Biological Chemistry|January 5, 2012
γδ T cell receptors recognize the non-classical major histocompatibility complex (MHC) molecule T22 via conserved anchor residues in a MHC peptide-like fashionAndrew Sandstrom, Louise Scharf, Gabrielle McRae, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2013
Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residuesAnthony P West, Louise Scharf, Joshua Horwitz, et al.
Cell|February 18, 2014
Structural insights on the role of antibodies in HIV-1 vaccine and therapyAnthony P West, Louise Scharf, Johannes F Scheid, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2013
Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibodyLouise Scharf, Anthony P West, Han Gao, et al.
Plos One|August 17, 2017
Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in miceFlavia Chiuppesi, Felix Wussow, Louise Scharf, et al.
Elife|May 27, 2017
Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodiesHaoqing Wang, Harry B Gristick, Louise Scharf, et al.
Pageof 3